|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Century Therapeutics, Inc. (IPSC) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
54,820,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Century Therapeutics is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with unmet medical need. Co.'s primary product candidate, CNTY-101, is an allogeneic, chimeric antigen receptors (CAR)-induce pluripotent stem cell-derived (iPSC-derived) natural killer (iNK) cell therapy that has been engineered to express CD19 CAR, soluble IL-15, an epidermal growth factor receptor safety switch, and also contains gene edits needed to incorporate Allo-Evasion™ technology. CNTY-103 is Co.'s main product candidate targeting a solid tumor.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
35,000 |
35,000 |
35,000 |
40,000 |
| Total Buy Value |
$17,329 |
$17,329 |
$17,329 |
$24,986 |
| Total People Bought |
1 |
1 |
1 |
2 |
| Total Buy Transactions |
1 |
1 |
1 |
2 |
| Total Shares Sold |
38,210 |
39,796 |
121,435 |
211,688 |
| Total Sell Value |
$17,642 |
$18,446 |
$72,636 |
$454,451 |
| Total People Sold |
3 |
4 |
5 |
5 |
| Total Sell Transactions |
3 |
7 |
21 |
42 |
| End Date |
2025-09-11 |
2025-06-10 |
2024-12-10 |
2023-12-11 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Carr Douglas |
SVP Finance & Operations |
• – – |
2025-12-08 |
4 |
S |
$0.53 |
$137 |
D/D |
(257) |
404,874 |
|
- |
|
| Cowan Chad |
Chief Scientific Officer |
• – – |
2025-11-20 |
4 |
S |
$0.50 |
$2,736 |
D/D |
(5,462) |
987,027 |
|
- |
|
| Pfeiffenberger Brent |
President and CEO |
• • – |
2025-11-19 |
4 |
B |
$0.50 |
$17,329 |
D/D |
35,000 |
3,271,453 |
0.01 |
- |
|
| Pfeiffenberger Brent |
President and CEO |
• • – |
2025-11-17 |
4 |
S |
$0.45 |
$14,735 |
D/D |
(32,456) |
3,236,453 |
|
- |
|
| Carr Douglas |
SVP Finance & Operations |
• – – |
2025-11-03 |
4 |
S |
$0.59 |
$171 |
D/D |
(292) |
405,131 |
|
- |
|
| Cowan Chad |
Chief Scientific Officer |
• – – |
2025-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
762,543 |
992,489 |
|
- |
|
| Russotti Gregory |
See Remarks |
• – – |
2025-09-08 |
4 |
S |
$0.50 |
$270 |
D/D |
(539) |
391,508 |
|
- |
|
| Pfeiffenberger Brent |
President and CEO |
• • – |
2025-09-08 |
4 |
S |
$0.50 |
$244 |
D/D |
(488) |
3,268,909 |
|
- |
|
| Carr Douglas |
SVP Finance & Operations |
• – – |
2025-09-08 |
4 |
S |
$0.50 |
$132 |
D/D |
(263) |
405,423 |
|
- |
|
| Pfeiffenberger Brent |
President and CEO |
• • – |
2025-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,587,614 |
3,269,397 |
|
- |
|
| Carr Douglas |
SVP Finance & Operations |
• – – |
2025-08-04 |
4 |
S |
$0.53 |
$158 |
D/D |
(296) |
405,686 |
|
- |
|
| Russotti Gregory |
See Remarks |
• – – |
2025-06-09 |
4 |
S |
$0.62 |
$327 |
D/D |
(526) |
392,047 |
|
- |
|
| Pfeiffenberger Brent |
President and CEO |
• • – |
2025-06-09 |
4 |
S |
$0.62 |
$295 |
D/D |
(475) |
1,681,783 |
|
- |
|
| Farid Adrienne |
Chief Operations Officer |
• – – |
2025-06-09 |
4 |
S |
$0.62 |
$343 |
D/D |
(552) |
250,141 |
|
- |
|
| Carr Douglas |
SVP Finance & Operations |
• – – |
2025-06-09 |
4 |
S |
$0.62 |
$3,050 |
D/D |
(4,904) |
405,982 |
|
- |
|
| Pfeiffenberger Brent |
President and CEO |
• • – |
2025-05-16 |
4 |
S |
$0.55 |
$16,135 |
D/D |
(29,552) |
1,682,258 |
|
- |
|
| Farid Adrienne |
Chief Operations Officer |
• – – |
2025-05-05 |
4 |
S |
$0.55 |
$563 |
D/D |
(1,024) |
250,693 |
|
- |
|
| Carr Douglas |
SVP Finance & Operations |
• – – |
2025-05-05 |
4 |
S |
$0.55 |
$162 |
D/D |
(295) |
410,886 |
|
- |
|
| Cowan Chad |
Chief Scientific Officer |
• – – |
2025-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
19,500 |
230,306 |
|
- |
|
| Conn Morgan |
Chief Finanical Officer |
• – – |
2025-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
19,500 |
79,648 |
|
- |
|
| Pfeiffenberger Brent |
President and CEO |
• • – |
2025-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
521,500 |
1,711,810 |
|
- |
|
| Russotti Gregory |
See Remarks |
• – – |
2025-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
392,573 |
|
- |
|
| Carr Douglas |
SVP Finance & Operations |
• – – |
2025-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
95,625 |
411,181 |
|
- |
|
| Farid Adrienne |
Chief Operations Officer |
• – – |
2025-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
251,717 |
|
- |
|
| Pfeiffenberger Brent |
President and CEO |
• • – |
2025-03-10 |
4 |
S |
$0.62 |
$1,375 |
D/D |
(2,235) |
1,190,310 |
|
- |
|
104 Records found
|
|
Page 1 of 5 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
